We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.87%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$254M
AUM Growth
+$5.76M
(+2.3%)
Cap. Flow
+$40.4M
Cap. Flow
% of AUM
15.92%
Top 10 Holdings %
Top 10 Hldgs %
57%
Holding
82
New
16
Increased
14
Reduced
8
Closed
18
Top Buys
| 1 |
Organon & Co
OGN
|
+$20.1M |
| 2 |
Cencora
COR
|
+$15.3M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
+$13.4M |
| 4 |
HCA Healthcare
HCA
|
+$13.3M |
| 5 |
Medtronic
MDT
|
+$8.11M |
Top Sells
| 1 |
Merck
MRK
|
+$16M |
| 2 |
Sanofi
SNY
|
+$15.4M |
| 3 |
Labcorp
LH
|
+$13M |
| 4 |
McKesson
MCK
|
+$10.6M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$9.1M |
Sector Composition
| 1 | Healthcare | 88.2% |
| 2 | Financials | 8.95% |
| 3 | Consumer Staples | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cencora
COR
$58.3B
| $25.9M | 10.22% |
183,334
+100,063
| +120% | +$15.3M |
|
|
MSAC
2
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $22.7M | 8.95% |
2,323,000
| – | – |
|
|
3
Organon & Co
OGN
$3.55B
| $19.4M | 7.64% |
+574,855
| New | +$20.1M |
|
4
Cigna
CI
$77.9B
| $14M | 5.51% |
53,034
-14,796
| -22% | -$3.81M |
|
5
Inogen
INGN
$175M
| $12.7M | 5.01% |
525,438
+125,352
| +31% | +$3.33M |
|
|
BCYC
6
Bicycle Therapeutics
BCYC
$291M
| $11.6M | 4.55% |
688,989
+636,201
| +1,205% | +$13.4M |
|
7
Centene
CNC
$32.5B
| $10.9M | 4.3% |
129,011
+32,249
| +33% | +$2.68M |
|
|
8
HCA Healthcare
HCA
$81.8B
| $10.4M | 4.1% |
+61,953
| New | +$13.3M |
|
9
United Therapeutics
UTHR
$22.1B
| $9.42M | 3.71% |
39,959
-15,303
| -28% | -$3.11M |
|
|
NARI
10
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.65M | 3.01% |
112,466
+72,256
| +180% | +$5.19M |
|
11
Biogen
BIIB
$27.7B
| $7.32M | 2.88% |
+35,900
| New | +$7.34M |
|
|
12
Medtronic
MDT
$102B
| $7.18M | 2.83% |
+80,000
| New | +$8.11M |
|
13
Sight Sciences
SGHT
$272M
| $6.52M | 2.57% |
+724,944
| New | +$6.38M |
|
|
NTUS
14
DELISTED
Natus Medical Inc
NTUS
| $6.26M | 2.47% |
190,956
-608
| -0.3% | -$19.2K |
|
15
Cardinal Health
CAH
$53.1B
| $6.22M | 2.45% |
+119,061
| New | +$6.77M |
|
16
Tenet Healthcare
THC
$16B
| $5.52M | 2.17% |
+105,000
| New | +$7.31M |
|
17
Vanda Pharmaceuticals
VNDA
$346M
| $5.33M | 2.1% |
488,965
+326,487
| +201% | +$3.38M |
|
|
BHVN
18
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.1M | 2.01% |
+35,000
| New | +$4.47M |
|
19
SkinHealth Systems
SKIN
$111M
| $4.66M | 1.84% |
+362,294
| New | +$4.85M |
|
|
INBX
20
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.14M | 1.63% |
365,210
+240,960
| +194% | +$3.54M |
|
21
Universal Health Services
UHS
$8.77B
| $4.1M | 1.62% |
+40,725
| New | +$5.1M |
|
|
HSKA
22
DELISTED
Heska Corp
HSKA
| $3.74M | 1.47% |
+39,566
| New | +$4.27M |
|
|
PNT
23
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.44M | 1.35% |
504,545
+126,861
| +34% | +$971K |
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.19M | 1.26% |
+40,000
| New | +$3.79M |
|
25
Modular Medical
MODD
$24.3M
| $2.98M | 1.17% |
+19,145
| New | +$2.62M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA